Company / Interest Expense per Share
Lilly (Eli) Interest Expense per Share History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.37
FY2023
5-year range
$0.37 / $0.43
FY2019-FY2023
Trend
-5.4%
vs FY2022
Sector context
#15 of 43
Health Care
What the data says
At $0.37, Lilly (Eli)'s interest expense per share ranks #29 of 43 in the Health Care sector. Interest Expense per Share has fluctuated over the past 8 years, ranging from $0.15 in FY2017 to $0.43 in FY2021.
Based on SEC 10-K filings.
0.37 in FY2023 with a 5-year CAGR of +10.3%.
Improved from $0.43 to $0.37 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +16.7%
- 5-Year CAGR
- +10.3%
- 10-Year CAGR
- -
Sector benchmark
#29 of 43 in Health CareTop 65% of 43This company $0.37 Sector average $9.80
▼
-96.2% below sector average
Key checks
Key Insights
- In FY2023, interest expense per share decreased 5.4% year-over-year.
- Ranks #15 out of 43 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2021.
- Lowest interest expense per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 1.02 (distress zone, below 1.8 threshold)
- Strong profit margin: 31.0%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 77.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.37 | -5.4% |
| FY2022 | $0.39 | -8.0% |
| FY2021 | $0.43 | +82.5% |
| FY2020 | $0.23 | -38.4% |
| FY2019 | $0.38 | +66.7% |
| FY2018 | $0.23 | +51.0% |
| FY2017 | $0.15 | -12.3% |
| FY2016 | $0.17 | +16.0% |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026